Satellos Bioscience Inc. (MSCLF)
USD 0.62
(-0.06%)
USD 0.62
(-0.06%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 44.29 Million CAD | 614.64% |
| 2022 | 6.19 Million CAD | -50.75% |
| 2021 | 12.58 Million CAD | 1014.37% |
| 2020 | 1.12 Million CAD | -23.08% |
| 2019 | 1.46 Million CAD | 724.06% |
| 2018 | 178.17 Thousand CAD | -87.05% |
| 2017 | 1.37 Million CAD | -43.9% |
| 2016 | 2.45 Million CAD | -37.06% |
| 2015 | 3.89 Million CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 33.19 Million CAD | -13.23% |
| 2024 Q1 | 38.25 Million CAD | -13.64% |
| 2023 Q4 | 44.29 Million CAD | -8.99% |
| 2023 FY | 44.29 Million CAD | 614.64% |
| 2023 Q3 | 48.67 Million CAD | -8.28% |
| 2023 Q2 | 53.07 Million CAD | 652.99% |
| 2023 Q1 | 7.04 Million CAD | 13.7% |
| 2022 Q4 | 6.19 Million CAD | -39.37% |
| 2022 Q2 | 9.09 Million CAD | -12.51% |
| 2022 Q1 | 10.39 Million CAD | -17.41% |
| 2022 FY | 6.19 Million CAD | -50.75% |
| 2022 Q3 | 10.22 Million CAD | 12.4% |
| 2021 Q2 | 9.15 Million CAD | 319.04% |
| 2021 Q1 | 2.18 Million CAD | 93.47% |
| 2021 Q4 | 12.58 Million CAD | -12.51% |
| 2021 FY | 12.58 Million CAD | 1014.37% |
| 2021 Q3 | 14.38 Million CAD | 57.11% |
| 2020 Q4 | 1.12 Million CAD | 0.0% |
| 2020 FY | 1.12 Million CAD | -23.08% |
| 2020 Q1 | - CAD | 0.0% |
| 2019 FY | 1.46 Million CAD | 724.06% |
| 2018 FY | 178.17 Thousand CAD | -87.05% |
| 2017 FY | 1.37 Million CAD | -43.9% |
| 2016 FY | 2.45 Million CAD | -37.06% |
| 2015 FY | 3.89 Million CAD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| RegeneRx Biopharmaceuticals, Inc. | 382.17 Thousand USD | -11490.964% |
| CSL Limited | 38.02 Billion USD | 99.883% |
| Eiger BioPharmaceuticals, Inc. | 38.84 Million USD | -14.032% |
| Nanobac Pharmaceuticals, Incorporated | 7.21 Million USD | -513.566% |
| Institute of Biomedical Research Corp. | 76.35 Thousand USD | -57916.607% |
| Evofem Biosciences, Inc. | 10.55 Million USD | -319.727% |
| Santhera Pharmaceuticals Holding AG | 130.21 Million USD | 65.98% |
| Propanc Biopharma, Inc. | 72.36 Thousand USD | -61114.676% |
| Mesoblast Limited | 667.9 Million USD | 93.368% |
| Marizyme, Inc. | 22.01 Million USD | -101.217% |
| Genus plc | 1.02 Billion USD | 95.695% |
| VioQuest Pharmaceuticals, Inc. | 1.35 Million USD | -3161.155% |
| CNBX Pharmaceuticals Inc. | 499.03 Thousand USD | -8776.661% |
| Nymox Pharmaceutical Corporation | 627 Thousand USD | -6965.072% |
| ContraFect Corporation | 20.67 Million USD | -114.217% |
| PsyBio Therapeutics Corp. | 390.36 Thousand USD | -11247.812% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| IMV Inc. | 31.33 Million USD | -41.375% |
| AXIM Biotechnologies, Inc. | 4.14 Million USD | -968.446% |
| MultiCell Technologies, Inc. | 126.22 USD | -35095764.364% |
| Accustem Sciences Inc. | 939.68 Thousand USD | -4614.113% |
| RVL Pharmaceuticals plc | 128.51 Million USD | 65.53% |
| EV Biologics, Inc. | 431.71 Thousand USD | -10160.96% |
| Q BioMed Inc. | 3.51 Million USD | -1160.071% |
| Emmaus Life Sciences, Inc. | 35.17 Million USD | -25.922% |
| Mosaic ImmunoEngineering Inc. | 261.27 Thousand USD | -16854.42% |
| Biomind Labs Inc. | 73.81 Thousand USD | -59908.941% |
| Oncotelic Therapeutics, Inc. | 30.01 Million USD | -47.586% |
| Skye Bioscience, Inc. | 11.94 Million USD | -270.992% |
| SQZ Biotechnologies Company | 107.18 Million USD | 58.672% |
| THC Farmaceuticals, Inc. | 2.74 Million USD | -1512.986% |
| Arch Therapeutics, Inc. | 1.95 Million USD | -2162.192% |
| Intellipharmaceutics International Inc. | 1.43 Million USD | -2993.367% |
| Acro Biomedical Co., Ltd. | 687.48 Thousand USD | -6343.477% |
| Neon Bloom, Inc. | 770.64 Thousand USD | -5648.179% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 462.85 Million USD | 90.429% |
| Therapeutic Solutions International, Inc. | 3.31 Million USD | -1237.091% |
| Curative Biotechnology, Inc. | 2.6 Million USD | -1601.677% |
| GB Sciences, Inc. | 103.44 Thousand USD | -42723.998% |
| Alpha Cognition Inc. | 2.45 Million USD | -1706.482% |
| argenx SE | 4.54 Billion USD | 99.025% |
| HST Global, Inc. | 1526.00 USD | -2902783.355% |
| Halberd Corporation | 10.13 Thousand USD | -437151.999% |
| Enzolytics Inc. | 361.7 Million USD | 87.753% |
| Resverlogix Corp. | 8.11 Million USD | -445.878% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| Nuo Therapeutics, Inc. | 1.87 Million USD | -2258.937% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 27.94 Million USD | -58.524% |
| American Oriental Bioengineering, Inc. | 446.3 Million USD | 90.075% |
| Enzon Pharmaceuticals, Inc. | 47.7 Million USD | 7.136% |
| Provectus Biopharmaceuticals, Inc. | 1.44 Million USD | -2957.474% |
| Endonovo Therapeutics, Inc. | 639.65 Thousand USD | -6825.285% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 22.78 Thousand USD | -194351.517% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 8.94 Million USD | -394.996% |
| AVAX Technologies, Inc. | 7.37 Million USD | -500.475% |
| ONE Bio Corp. | 70.08 Million USD | 36.794% |
| Zenith Capital Corp. | 7410.00 USD | -597713.765% |
| Genscript Biotech Corporation | 3.38 Billion USD | 98.692% |
| Ember Therapeutics, Inc. | 184.00 USD | -24074900.0% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 321.8 Thousand USD | -13665.436% |
| WPD Pharmaceuticals Inc. | 261.36 Thousand USD | -16848.776% |
| Cotinga Pharmaceuticals Inc. | 927.96 Thousand USD | -4673.692% |
| Wesana Health Holdings Inc. | 987.96 Thousand USD | -4383.753% |
| Agentix Corp. | 261.39 Thousand USD | -16846.961% |
| Adynxx, Inc. | - USD | -Infinity% |
| Kadimastem Ltd | 2.3 Million USD | -1822.589% |
| Helix BioMedix, Inc. | 3.02 Million USD | -1364.355% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 52.7 Million USD | 15.945% |
| BioStem Technologies, Inc. | 14.56 Million USD | -204.238% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 57.09 Thousand USD | -77487.838% |
| Burzynski Research Institute, Inc. | 2310.00 USD | -1917562.338% |
| LadRx Corporation | 2.3 Million USD | -1819.422% |
| Cell Source, Inc. | 195.17 Thousand USD | -22597.02% |
| ProtoKinetix, Incorporated | 480.55 Thousand USD | -9118.053% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -12427.113% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -12427.113% |
| NovAccess Global Inc. | 62.24 Thousand USD | -71063.732% |
| Affymax, Inc. | 7.44 Million USD | -495.163% |
| Itoco Inc. | 1.4 Million USD | -3063.98% |
| Rasna Therapeutics, Inc. | 95.65 Thousand USD | -46209.209% |
| Pathfinder Cell Therapy, Inc. | 106 Thousand USD | -41690.566% |
| CytoDyn Inc. | 11.13 Million USD | -297.791% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 142.97 Thousand USD | -30883.689% |
| NanoSphere Health Sciences Inc. | 17.88 Thousand USD | -247651.678% |
| Qrons Inc. | 420.00 USD | -10547042.857% |
| Alseres Pharmaceuticals, Inc. | 385.47 Thousand USD | -11391.915% |
| SYBLEU INC | 330.46 Thousand USD | -13304.626% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 552.12 Thousand USD | -7923.256% |
| Rebus Holdings, Inc. | 5000.00 USD | -885860.0% |
| ImmunoCellular Therapeutics, Ltd. | 409.42 Thousand USD | -10719.643% |
| Mobile Lads Corp. | 52.00 USD | -85188361.538% |
| International Stem Cell Corporation | 5.39 Million USD | -721.855% |
| Bioxytran, Inc. | 137.63 Thousand USD | -32084.426% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 15 Million USD | -195.284% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 16.57 Million USD | -167.193% |
| Adhera Therapeutics, Inc. | 79 Thousand USD | -55973.418% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 864.67 Thousand USD | -5023.069% |
| Innovation Pharmaceuticals Inc. | 7.51 Million USD | -489.304% |
| Neutra Corp. | 2851.00 USD | -1553670.607% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | -36.697% |
| PureTech Health plc | 693.97 Million USD | 93.617% |
| Coeptis Therapeutics, Inc. | 8.07 Million USD | -448.848% |
| IXICO plc | 15.84 Million USD | -179.59% |
| IntelGenx Technologies Corp. | 8.28 Million USD | -434.871% |
| Gelesis Holdings, Inc. | 103.32 Million USD | 57.127% |
| CSL Limited | 38.02 Billion USD | 99.883% |
| Cellectis S.A. | 333.99 Million USD | 86.737% |